Akari Therapeutics Plc

AKTX - Company ID 0001541157

Market cap-

Rank-

Filings710

Akari Therapeutics Plc has filed 710 public company documents between 2012 and 2026. The most frequent type is 6-k (188 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.

Continue researchAKTX overviewCompany snapshotMarket cap, financials, charts, and latest company context.

Continue researchMarket cap historyLive rankingSee the market value trend behind the filing history.

Continue researchRevenue trendAnnual historyMove from documents into filing-backed operating results.

Continue researchCompare with LLYPeer viewPut AKTX beside LLY across market cap, revenue, income, and filings.

Browse latest filings across all companies →Follow AKTX via RSS

Similar companies to research next

LLYEli Lilly and Company

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.

Type	Filing	Filed	Period covered	Open
PRE 14A	PRE 14A	1mo ago2026-05-22	2026-05-22	View filing
8-K	Major company event	1mo ago2026-05-22	2026-05-20	View filing
RW	RW	1mo ago2026-05-21	-	View filing
10-Q	Quarterly report	1mo ago2026-05-19	2026-03-31	View filing
NT 10-Q	NT 10-Q	1mo ago2026-05-18	2026-03-31	View filing
S-1	IPO registration	2mo ago2026-05-08	-	View filing
EFFECT	EFFECT	2mo ago2026-04-15	-	View filing
POS AM	POS AM	3mo ago2026-04-10	-	View filing
DRS	DRS	3mo ago2026-04-02	-	View filing
F-6/A	F-6/A	3mo ago2026-03-31	-	View filing
10-K	Annual report	3mo ago2026-03-30	2025-12-31	View filing
8-K	Major company event	3mo ago2026-03-17	2026-03-17	View filing
4	Insider trade	3mo ago2026-03-16	2025-12-16	View filing
SCHEDULE 13D/A	SCHEDULE 13D/A	4mo ago2026-03-04	-	View filing
SCHEDULE 13D/A	SCHEDULE 13D/A	4mo ago2026-03-04	-	View filing
SCHEDULE 13G/A	SCHEDULE 13G/A	4mo ago2026-03-04	-	View filing
8-K	Major company event	4mo ago2026-03-02	2026-03-02	View filing
DEF 14A	Proxy statement	5mo ago2026-02-02	2026-02-02	View filing
EFFECT	EFFECT	5mo ago2026-01-29	-	View filing
CORRESP	Company correspondence	5mo ago2026-01-27	-	View filing
UPLOAD	SEC correspondence	5mo ago2026-01-27	-	View filing
S-1	IPO registration	5mo ago2026-01-23	-	View filing
PRE 14A	PRE 14A	5mo ago2026-01-22	2026-01-22	View filing
4	Insider trade	6mo ago2025-12-18	2025-12-16	View filing
4	Insider trade	6mo ago2025-12-18	2025-12-16	View filing
4	Insider trade	6mo ago2025-12-18	2025-12-16	View filing
4	Insider trade	6mo ago2025-12-18	2025-12-16	View filing
4	Insider trade	6mo ago2025-12-18	2025-12-16	View filing
4	Insider trade	6mo ago2025-12-18	2025-12-16	View filing
4	Insider trade	6mo ago2025-12-18	2025-12-16	View filing
8-K	Major company event	6mo ago2025-12-17	2025-12-16	View filing
424B5	Prospectus supplement	6mo ago2025-12-17	-	View filing
8-K	Major company event	6mo ago2025-12-16	2025-12-15	View filing
8-K	Major company event	7mo ago2025-12-08	2025-12-08	View filing
424B3	424B3	7mo ago2025-12-05	-	View filing
EFFECT	EFFECT	7mo ago2025-12-02	-	View filing
CORRESP	Company correspondence	7mo ago2025-12-01	-	View filing
8-K	Major company event	7mo ago2025-11-26	2025-11-24	View filing
DEF 14A	Proxy statement	7mo ago2025-11-17	2025-11-17	View filing
S-1	IPO registration	7mo ago2025-11-17	-	View filing
10-Q	Quarterly report	7mo ago2025-11-13	2025-09-30	View filing
PRE 14A	PRE 14A	8mo ago2025-11-07	2025-11-07	View filing
4	Insider trade	8mo ago2025-11-04	2025-11-01	View filing
4	Insider trade	8mo ago2025-10-24	2025-10-22	View filing
3	New insider ownership	8mo ago2025-10-24	2025-10-22	View filing
D	D	8mo ago2025-10-24	-	View filing
8-K	Major company event	8mo ago2025-10-23	2025-10-22	View filing
8-K	Major company event	8mo ago2025-10-16	2025-10-14	View filing
424B5	Prospectus supplement	8mo ago2025-10-16	-	View filing
8-K	Major company event	8mo ago2025-10-15	2025-10-15	View filing

Akari Therapeutics Plc

Similar companies to research next

Year